Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Convertible Debt (2016 - 2019)

Sanara MedTech's Convertible Debt history spans 9 years, with the latest figure at $1.5 million for Q4 2019.

  • For Q4 2019, Convertible Debt changed N/A year-over-year to $1.5 million; the TTM value through Dec 2019 reached $1.5 million, changed N/A, while the annual FY2019 figure was $1.5 million, N/A changed from the prior year.
  • Convertible Debt reached $1.5 million in Q4 2019 per SMTI's latest filing, roughly flat from $1.5 million in the prior quarter.
  • In the past five years, Convertible Debt ranged from a high of $1.5 million in Q3 2018 to a low of $1.2 million in Q4 2015.
  • Average Convertible Debt over 5 years is $1.3 million, with a median of $1.2 million recorded in 2015.
  • The largest YoY upside for Convertible Debt was 0.0% in 2016 against a maximum downside of 0.0% in 2016.
  • A 5-year view of Convertible Debt shows it stood at $1.2 million in 2015, then changed by 0.0% to $1.2 million in 2016, then changed by 0.0% to $1.2 million in 2017, then increased by 25.0% to $1.5 million in 2018, then changed by 0.0% to $1.5 million in 2019.
  • Per Business Quant, the three most recent readings for SMTI's Convertible Debt are $1.5 million (Q4 2019), $1.5 million (Q3 2019), and $1.5 million (Q2 2019).